Search For "emergency use"
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 4 years ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12
Updated : 4 years ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company on Tuesday.
Read More
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children
Updated : 4 years ago IST
Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine (ZycovD) for COVID-19 as a two-dose vaccine for children above the age of 12 years, said Zydus Lifesciences Ltd., the phar
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 4 years ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Subject Expert Panel recommends Corbevax COVID-19 vaccines for children ag
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has recommended restricted emergency use of Biological E's Corbevax COVID-19 vaccine for children aged 5-11, said sources on Thursday.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
FDA authorizes first-ever breathing test for detecting COVID-19 infection
Updated : 4 years, 1 month ago IST
Washington [US], April 16 (ANI): The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.
Read More
Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents
Updated : 4 years, 2 months ago IST
New Delhi [India], March 23 (ANI): Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India.
Read More
Moderna requests FDA to authorize second COVID-19 booster shot for adults
Updated : 4 years, 2 months ago IST
Washington [US], March 18 (ANI/Xinhua): American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already recei
Read More
DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax
Updated : 4 years, 2 months ago IST
New Delhi [India], March 9 (ANI): The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years.
Read More
Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age
Updated : 4 years, 2 months ago IST
New Delhi [India], March 9 (ANI): Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday.
Read More
SEC recommends granting emergency use authorisation to Serum Institute of
Updated : 4 years, 2 months ago IST
New Delhi [India], March 4 (ANI): The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine Covovax for the age group 12-17, said the official sources.
Read More